Funding and Collaborations

Virology

Head of Institute:
Prof. Dr. med. Klaus Überla

Funding

  • Deutsche Forschungsgemeinschaft, SFB 796, „Reprogramming of host cells by microbial effectors“, Teilprojekt C3
  • Deutsche Forschungsgemeinschaft M. Marschall (MA1289/7-3, MA1289/8-1, MA1289/11-1)
  • Deutsche Forschungsgemeinschaft J. Milbradt/M. Marschall (MI2143/2-1)
  • Bayerische Forschungsstiftung (ForBiMed-Forschungsverbund, Teilprojekt I1)
  • Wilhelm Sander-Stiftung (2018.121.1)
  • DAAD-Go8, German-Australian Joint Research Program (ID 5439 0135)

Collaborations

  • Dr. Eva Maria Borst and Prof. Dr. Martin Messerle, Department of Virology, Hannover Medical School, Hannover, Germany
  • Prof. Dr. Sunwen Chou, Division of Infectious Diseases, Oregon Health and Science University, Portland, Oregon, USA
  • Dr. Yohann Couté, Laboratoire Biologie à Grande Echelle (BGE), Exploring the Dynamics of Proteomes (EDyP), INSERM/CEA/Université Grenoble, France
  • Prof. Dr. Jutta Eichler, Department of Chemistry and Pharmacy, FAU Erlangen-Nürnberg, Germany
  • Dr. Jan Eickhoff, Dr. Tim Bergbrede and Dr. Bert Klebl, Lead Discovery Center GmbH, Dortmund
  • Prof. Dr. Felix Engel, Division of Nephropathology, Translational Research Center Erlangen (TRC) of the Medical Center of FAU Erlangen-Nürnberg, Germany
  • Prof. Dr. Torgils Fossen, Department of Chemistry, University of Bergen, Norway
  • Dr. Joachim Haupt and Prof. Dr. Michael Schroeder, Biotechnology Center, Technische Universit€at Dresden, Dresden, Germany
  • Prof. Dr. Benedikt Kaufer, Institute of Virology, Free University of Berlin, Germany
  • Prof. Dr. Santo Landolfo, Department of Public Health and Pediatric Sciences, University of Turin, Italy
  • Dr. Tihana Lenac and Prof. Dr. Stipan Jonjic, Department of Histology and Embryology, University of Rijeka, Croatia
  • Dr. Peter Lischka and Dr. Holger Zimmermann, AiCuris Anti-infective Cures GmbH, Wuppertal, Germany
  • Prof. Dr. Yves Muller, Division of Biotechnology, Department of Biology, FAU Erlangen-Nürnberg, Germany
  • Dr. László Örfi, Vichem Chemie Ltd., Budapest & Semmelweis University, Department of Pharmaceutical Chemistry, Budapest, Hungary
  • Prof. Dr. Bodo Plachter, Institute for Virology, University of Mainz, Germany
  • Prof. Dr. William D. Rawlinson, Dr. Stuart Hamilton & Coworkers, Virology Division, Microbiology Department, University NSW, Prince of Wales Hospital, Sydney, Australia
  • Prof. Dr. Bimalendu Ray and Prof. Dr. Sayani Ray, Department of Chemistry, Natural Products Laboratory, University of Burdwan, WB, India
  • Prof. Dr. Ursula Schlötzer-Schrehardt, Department of Ophthalmology, FAU Erlangen-Nürnberg, Germany
  • Prof. Dr. Uwe Sonnewald, Division of Biochemistry, Department of Biology, FAU Erlangen-Nürnberg, Germany
  • Prof. Dr. Thomas Stamminger, Institute for Virology, University of Ulm, Germany
  • Prof. Dr. Heinrich Sticht, Division of Bioinformatics, Institute of Biochemistry, FAU Erlangen-Nürnberg, Germany
  • Dr. Stefan Strobl*, Dr. Christophe Henry and Dr. Daniel Vitt, 4SC AG, Martinsried, Germany (* novel affiliation 2016: BioNTech Small Molecules, Martinsried, Germany)
  • Prof. Dr. Svetlana Tsogoeva, Institute of Organic Chemistry, FAU Erlangen-Nürnberg, Germany